1771PHypothyroidism in cancer patients received multikinase inhibitors: Risk factors and outcomes

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of oncology 2018-10, Vol.29 (suppl_8)
Hauptverfasser:	Hansuranant, S, Nimitphong, H, Pattanaprateep, O, Phraewphiphat, R, Muntham, D, Reungwetwattana, T
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue	suppl_8
container_start_page
container_title	Annals of oncology
container_volume	29
creator	Hansuranant, S Nimitphong, H Pattanaprateep, O Phraewphiphat, R Muntham, D Reungwetwattana, T
description
doi_str_mv	10.1093/annonc/mdy300.087
format	Article
fullrecord	<record><control><sourceid>oup</sourceid><recordid>TN_cdi_oup_primary_10_1093_annonc_mdy300_087</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/annonc/mdy300.087</oup_id><sourcerecordid>10.1093/annonc/mdy300.087</sourcerecordid><originalsourceid>FETCH-oup_primary_10_1093_annonc_mdy300_0873</originalsourceid><addsrcrecordid>eNqVz8FqAjEUheEgFTqtfYDu7gN09MaoY7otLS5F3Ic0E_FWkwy5GWHevop9ga4OB_7NJ8SrxKlErWY2xhTdLLSDQpziuhmJSi5Xul7jQj6ICvVc1c1SLR7FE_MPIq70XFfCyqaR283QpXIccqKWOABFcDY6n6GzhXwsDNk7TxffQujPhU4ULftrd6RvKinzO-yIT3Cw7vbAxhZSX1wKnidifLBn9i9_-yzevj73H5s69Z3pMgWbByPR3BjmzjB3hrky1D_zX905VBk</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>1771PHypothyroidism in cancer patients received multikinase inhibitors: Risk factors and outcomes</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Hansuranant, S ; Nimitphong, H ; Pattanaprateep, O ; Phraewphiphat, R ; Muntham, D ; Reungwetwattana, T</creator><creatorcontrib>Hansuranant, S ; Nimitphong, H ; Pattanaprateep, O ; Phraewphiphat, R ; Muntham, D ; Reungwetwattana, T</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdy300.087</identifier><language>eng</language><publisher>Oxford University Press</publisher><ispartof>Annals of oncology, 2018-10, Vol.29 (suppl_8)</ispartof><rights>The Author(s) 2018. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. 2018</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Hansuranant, S</creatorcontrib><creatorcontrib>Nimitphong, H</creatorcontrib><creatorcontrib>Pattanaprateep, O</creatorcontrib><creatorcontrib>Phraewphiphat, R</creatorcontrib><creatorcontrib>Muntham, D</creatorcontrib><creatorcontrib>Reungwetwattana, T</creatorcontrib><title>1771PHypothyroidism in cancer patients received multikinase inhibitors: Risk factors and outcomes</title><title>Annals of oncology</title><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNqVz8FqAjEUheEgFTqtfYDu7gN09MaoY7otLS5F3Ic0E_FWkwy5GWHevop9ga4OB_7NJ8SrxKlErWY2xhTdLLSDQpziuhmJSi5Xul7jQj6ICvVc1c1SLR7FE_MPIq70XFfCyqaR283QpXIccqKWOABFcDY6n6GzhXwsDNk7TxffQujPhU4ULftrd6RvKinzO-yIT3Cw7vbAxhZSX1wKnidifLBn9i9_-yzevj73H5s69Z3pMgWbByPR3BjmzjB3hrky1D_zX905VBk</recordid><startdate>20181001</startdate><enddate>20181001</enddate><creator>Hansuranant, S</creator><creator>Nimitphong, H</creator><creator>Pattanaprateep, O</creator><creator>Phraewphiphat, R</creator><creator>Muntham, D</creator><creator>Reungwetwattana, T</creator><general>Oxford University Press</general><scope/></search><sort><creationdate>20181001</creationdate><title>1771PHypothyroidism in cancer patients received multikinase inhibitors: Risk factors and outcomes</title><author>Hansuranant, S ; Nimitphong, H ; Pattanaprateep, O ; Phraewphiphat, R ; Muntham, D ; Reungwetwattana, T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-oup_primary_10_1093_annonc_mdy300_0873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hansuranant, S</creatorcontrib><creatorcontrib>Nimitphong, H</creatorcontrib><creatorcontrib>Pattanaprateep, O</creatorcontrib><creatorcontrib>Phraewphiphat, R</creatorcontrib><creatorcontrib>Muntham, D</creatorcontrib><creatorcontrib>Reungwetwattana, T</creatorcontrib><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hansuranant, S</au><au>Nimitphong, H</au><au>Pattanaprateep, O</au><au>Phraewphiphat, R</au><au>Muntham, D</au><au>Reungwetwattana, T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>1771PHypothyroidism in cancer patients received multikinase inhibitors: Risk factors and outcomes</atitle><jtitle>Annals of oncology</jtitle><date>2018-10-01</date><risdate>2018</risdate><volume>29</volume><issue>suppl_8</issue><issn>0923-7534</issn><eissn>1569-8041</eissn><pub>Oxford University Press</pub><doi>10.1093/annonc/mdy300.087</doi></addata></record>
fulltext	fulltext
identifier	ISSN: 0923-7534
ispartof	Annals of oncology, 2018-10, Vol.29 (suppl_8)
issn	0923-7534 1569-8041
language	eng
recordid	cdi_oup_primary_10_1093_annonc_mdy300_087
source	EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
title	1771PHypothyroidism in cancer patients received multikinase inhibitors: Risk factors and outcomes
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T04%3A57%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=1771PHypothyroidism%20in%20cancer%20patients%20received%20multikinase%20inhibitors:%20Risk%20factors%20and%20outcomes&rft.jtitle=Annals%20of%20oncology&rft.au=Hansuranant,%20S&rft.date=2018-10-01&rft.volume=29&rft.issue=suppl_8&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdy300.087&rft_dat=%3Coup%3E10.1093/annonc/mdy300.087%3C/oup%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_oup_id=10.1093/annonc/mdy300.087&rfr_iscdi=true